Conditions: Diabetic Nephropathy
Keywords: Diabetic Nephropathy Canagliflozin Canaglu Diabetes Mellitus, Type 2
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 308
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the efficacy and safety of Canagliflozin (TA-7284) in Japanese patients with Diabetic Nephropathy, compared with placebo

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Canagliflozin intervention 2: Placebo
Intervention descriptions: intervention 1: Canagliflozin 100mg orally once daily intervention 2: Placebo orally once daily

Protocol document:
Prot_000.pdf: 































































































































































SAP_001.pdf: